Page last updated: 2024-11-04

sb 206553 and Dementia

sb 206553 has been researched along with Dementia in 2 studies

SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kołaczkowski, M2
Marcinkowska, M2
Bucki, A2
Pawłowski, M2
Mitka, K1
Jaśkowska, J1
Kowalski, P1
Kazek, G1
Siwek, A2
Wasik, A1
Wesołowska, A2
Mierzejewski, P2
Bienkowski, P1
Śniecikowska, J1
Zagórska, A1
Jamrozik, M1
Głuch-Lutwin, M1
Jakubczyk, M1
Pytka, K1
Jastrzębska-Więsek, M1
Partyka, A1

Other Studies

2 other studies available for sb 206553 and Dementia

ArticleYear
Novel arylsulfonamide derivatives with 5-HT₆/5-HT₇ receptor antagonism targeting behavioral and psychological symptoms of dementia.
    Journal of medicinal chemistry, 2014, Jun-12, Volume: 57, Issue:11

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Avoidance Learning; Benzoxazoles; Catalepsy; C

2014
Multifunctional 6-fluoro-3-[3-(pyrrolidin-1-yl)propyl]-1,2-benzoxazoles targeting behavioral and psychological symptoms of dementia (BPSD).
    European journal of medicinal chemistry, 2020, Apr-01, Volume: 191

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzoxazoles; Dementia; Dizocilpine Maleate; Dose-R

2020